Antinori, A.

Updated research nosology for HIV-associated neurocognitive disorders

Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., Clifford, D. B., Cinque, P., Epstein, L. G., Goodkin, K., et al. (2007) · Neurology

HIV Research and TreatmentInfectious Diseases and Tuberculosis

Cited by 2,630

Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder:A consensus report of the mind exchange program

The Mind Exchange Working Group, Antinori, A., Arendt, G., Grant, I., Letendre, S., Chair, Munoz-Moreno, J. A., Eggers, C., Brew, B., Brouillette, M.-J., et al. (2013) · Clinical Infectious Diseases

HIV Research and TreatmentInfectious Diseases and Tuberculosis

Cited by 208

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition

Bibas, M., Pittalis, S., Orchi, N., De Carli, G., Agrati, C., Girardi, E., Antinori, A., Puro, V., & Ippolito, G. (2021) · Blood Cancer Journal

HIV/AIDS Research and InterventionsMultiple Myeloma Research and Treatments

Cited by 8

LDL TARGET IN PATIENTS WITH HIV AT HIGH CARDIOVASCULAR RISK: THE ROLE OF BEMPEDOIC ACID

Gatto, M., Moschella Orsini, F., Passarelli, I., & Antinori, A. (2024) · European Heart Journal Supplements

Lipoproteins and Cardiovascular HealthHIV-related health complications and treatments

Cited by 1